Cancers,
Год журнала:
2023,
Номер
15(15), С. 3817 - 3817
Опубликована: Июль 27, 2023
The
study
presents
‘G4-QuadScreen’,
a
user-friendly
computational
tool
for
identifying
MTDLs
against
G4s.
Also,
it
offers
few
hit
based
on
in
silico
and
vitro
approaches.
Multi-tasking
QSAR
models
were
developed
using
linear
discriminant
analysis
random
forest
machine
learning
techniques
predicting
the
responses
of
interest
(G4
interaction,
G4
stabilization,
selectivity,
cytotoxicity)
considering
variations
experimental
conditions
(e.g.,
sequences,
endpoints,
cell
lines,
buffers,
assays).
A
virtual
screening
with
G4-QuadScreen
molecular
docking
YASARA
(AutoDock-Vina)
was
performed.
activities
confirmed
via
FRET
melting,
FID,
viability
assays.
Validation
metrics
demonstrated
high
discriminatory
power
robustness
(the
accuracy
all
is
~>90%
training
sets
~>80%
external
sets).
evaluations
showed
that
ten
screened
have
capacity
to
selectively
stabilize
multiple
Three
induced
strong
inhibitory
effect
various
human
cancer
lines.
This
pioneering
serves
accelerate
search
new
leads
G4s,
reducing
false
positive
outcomes
early
stages
drug
discovery.
accessible
ChemoPredictionSuite
website.
ACS Central Science,
Год журнала:
2023,
Номер
9(5), С. 892 - 904
Опубликована: Апрель 26, 2023
Nature
has
evolved
intricate
machinery
to
target
and
degrade
RNA,
some
of
these
molecular
mechanisms
can
be
adapted
for
therapeutic
use.
Small
interfering
RNAs
RNase
H-inducing
oligonucleotides
have
yielded
agents
against
diseases
that
cannot
tackled
using
protein-centered
approaches.
Because
are
nucleic
acid-based,
they
several
inherent
drawbacks
which
include
poor
cellular
uptake
stability.
Here
we
report
a
new
approach
RNA
small
molecules,
proximity-induced
acid
degrader
(PINAD).
We
utilized
this
strategy
design
two
families
degraders
different
structures
within
the
genome
SARS-CoV-2:
G-quadruplexes
betacoronaviral
pseudoknot.
demonstrate
novel
molecules
their
targets
in
vitro,
cellulo,
vivo
SARS-CoV-2
infection
models.
Our
allows
any
binding
molecule
converted
into
degrader,
empowering
binders
not
potent
enough
exert
phenotypic
effect
on
own.
PINAD
raises
possibility
targeting
destroying
disease-related
species,
greatly
expand
space
druggable
diseases.
Briefings in Bioinformatics,
Год журнала:
2023,
Номер
24(4)
Опубликована: Май 25, 2023
Computational
analysis
of
RNA
sequences
constitutes
a
crucial
step
in
the
field
biology.
As
other
domains
life
sciences,
incorporation
artificial
intelligence
and
machine
learning
techniques
into
sequence
has
gained
significant
traction
recent
years.
Historically,
thermodynamics-based
methods
were
widely
employed
for
prediction
secondary
structures;
however,
learning-based
approaches
have
demonstrated
remarkable
advancements
years,
enabling
more
accurate
predictions.
Consequently,
precision
pertaining
to
structures,
such
as
RNA-protein
interactions,
also
been
enhanced,
making
substantial
contribution
Additionally,
are
introducing
technical
innovations
RNA-small
molecule
interactions
RNA-targeted
drug
discovery
design
aptamers,
where
serves
its
own
ligand.
This
review
will
highlight
trends
structure,
aptamers
using
learning,
deep
related
technologies,
discuss
potential
future
avenues
informatics.
ACS Medicinal Chemistry Letters,
Год журнала:
2023,
Номер
14(3), С. 251 - 259
Опубликована: Фев. 23, 2023
The
surprising
discovery
that
RNAs
are
the
predominant
gene
products
to
emerge
from
human
genome
catalyzed
a
renaissance
in
RNA
biology.
It
is
now
well-understood
act
as
more
than
just
messenger
and
comprise
large
diverse
family
of
ribonucleic
acids
differing
sizes,
structures,
functions.
play
expansive
roles
cell,
contributing
regulation
fine-tuning
nearly
all
aspects
expression
architecture.
In
line
with
significance
these
functions,
we
have
witnessed
an
explosion
discoveries
connecting
variety
diseases.
Consequently,
targeting
RNAs,
broadly
biology,
has
emerged
untapped
area
drug
discovery,
making
search
for
RNA-targeted
therapeutics
great
interest.
this
Microperspective,
I
highlight
contemporary
learnings
field
present
my
views
on
how
catapult
us
toward
systematic
medicines.
Briefings in Bioinformatics,
Год журнала:
2024,
Номер
25(2)
Опубликована: Янв. 22, 2024
Ribonucleic
acids
(RNAs)
play
important
roles
in
cellular
regulation.
Consequently,
dysregulation
of
both
coding
and
non-coding
RNAs
has
been
implicated
several
disease
conditions
the
human
body.
In
this
regard,
a
growing
interest
observed
to
probe
into
potential
act
as
drug
targets
conditions.
To
accelerate
search
for
disease-associated
novel
RNA
their
small
molecular
inhibitors,
machine
learning
models
binding
affinity
prediction
were
developed
specific
six
subtypes
namely,
aptamers,
miRNAs,
repeats,
ribosomal
RNAs,
riboswitches
viral
RNAs.
We
found
that
differences
sequence
composition,
flexibility
polar
nature
RNA-binding
ligands
are
predicting
affinity.
Our
method
showed
an
average
Pearson
correlation
(r)
0.83
mean
absolute
error
0.66
upon
evaluation
using
jack-knife
test,
indicating
reliability
despite
low
amount
data
available
subtypes.
Further,
validated
with
external
blind
test
datasets,
which
outperform
other
existing
quantitative
structure-activity
relationship
(QSAR)
models.
have
web
server
host
models,
RNA-Small
molecule
Affinity
Predictor,
is
freely
at:
https://web.iitm.ac.in/bioinfo2/RSAPred/.
Cell chemical biology,
Год журнала:
2024,
Номер
31(6), С. 1101 - 1117
Опубликована: Июнь 1, 2024
RNA-targeting
small
molecules
(rSMs)
have
become
an
attractive
modality
to
tackle
traditionally
undruggable
proteins
and
expand
the
druggable
space.
Among
many
innovative
concepts,
chimeras
(RNATACs)
represent
a
new
class
of
multispecific,
induced
proximity
that
act
by
chemically
bringing
RNA
targets
into
with
endogenous
effector,
such
as
ribonuclease
(RNase).
Depending
on
RNATACs
can
alter
stability,
localization,
translation,
or
splicing
target
RNA.
Although
still
in
its
infancy,
this
has
potential
for
broad
applications
future
treat
diseases
high
unmet
need.
In
review,
we
discuss
advantages
RNATACs,
recent
progress
field,
challenges
cutting-edge
technology.
Nature Communications,
Год журнала:
2024,
Номер
15(1)
Опубликована: Июль 8, 2024
Abstract
The
rational
targeting
of
RNA
with
small
molecules
is
hampered
by
our
still
limited
understanding
structural
and
dynamic
properties.
Most
in
silico
tools
for
binding
site
identification
rely
on
static
structures
therefore
cannot
face
the
challenges
posed
nature
molecules.
Here,
we
present
SHAMAN,
a
computational
technique
to
identify
potential
small-molecule
sites
ensembles.
SHAMAN
enables
exploring
conformational
landscape
atomistic
molecular
dynamics
simulations
at
same
time
identifying
pockets
an
efficient
way
aid
probes
enhanced-sampling
techniques.
In
benchmark
composed
large,
structured
riboswitches
as
well
small,
flexible
viral
RNAs,
successfully
identifies
all
experimentally
resolved
ranks
them
among
most
favorite
probe
hotspots.
Overall,
sets
solid
foundation
future
drug
design
efforts
molecules,
effectively
addressing
long-standing
field.
bioRxiv (Cold Spring Harbor Laboratory),
Год журнала:
2025,
Номер
unknown
Опубликована: Март 15, 2025
ABSTRACT
RNAs
are
critical
regulators
of
gene
expression,
and
their
functions
often
mediated
by
complex
secondary
tertiary
structures.
Structured
regions
in
RNA
can
selectively
interact
with
small
molecules
–
via
well-defined
ligand
binding
pockets
to
modulate
the
regulatory
repertoire
an
RNA.
The
broad
potential
biological
function
intentionally
RNA-ligand
interactions
remains
unrealized,
however,
due
challenges
identifying
compact
motifs
ability
bind
ligands
good
physicochemical
properties
(often
termed
drug-like).
Here,
we
devise
fpocketR
,
a
computational
strategy
that
accurately
detects
capable
drug-like
Remarkably
few,
roughly
50,
such
have
ever
been
visualized.
We
experimentally
confirmed
ligandability
novel
detected
using
fragment-based
approach
introduced
here,
Frag-MaP,
ligand-binding
sites
cells.
Analysis
validated
Frag-MaP
reveals
dozens
newly
identified
able
ligands,
supports
model
for
structural
quality
creates
framework
understanding
ligand-ome.
Expert Opinion on Drug Discovery,
Год журнала:
2024,
Номер
19(4), С. 415 - 431
Опубликована: Фев. 6, 2024
Introduction
Targeting
RNAs
with
small
molecules
offers
an
alternative
to
the
conventional
protein-targeted
drug
discovery
and
can
potentially
address
unmet
emerging
medical
needs.
The
recent
rise
of
interest
in
strategy
has
already
resulted
large
amounts
data
on
disease
associated
RNAs,
as
well
that
bind
such
RNAs.
Artificial
intelligence
(AI)
approaches,
including
machine
learning
deep
learning,
present
opportunity
speed
up
RNA-targeted
by
improving
decision-making
efficiency
quality.
ACS Medicinal Chemistry Letters,
Год журнала:
2023,
Номер
14(6), С. 757 - 765
Опубликована: Май 11, 2023
Targeting
structured
RNA
elements
in
the
SARS-CoV-2
viral
genome
with
small
molecules
is
an
attractive
strategy
for
pharmacological
control
over
replication.
In
this
work,
we
report
discovery
of
that
target
frameshifting
element
(FSE)
using
high-throughput
small-molecule
microarray
(SMM)
screening.
A
new
class
aminoquinazoline
ligands
FSE
are
synthesized
and
characterized
multiple
orthogonal
biophysical
assays
structure–activity
relationship
(SAR)
studies.
This
work
reveals
compounds
mid-micromolar
binding
affinity
(KD
=
60
±
6
μM)
to
supports
a
mode
distinct
from
previously
reported
binders
MTDB
merafloxacin.
addition,
active
vitro
dual-luciferase
in-cell
dual-fluorescent-reporter
assays,
highlighting
promise
targeting
RNAs
druglike
alter
expression
proteins.